19-19096156-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178526.5(SLC25A42):c.32G>A(p.Arg11Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,613,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_178526.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC25A42 | NM_178526.5 | c.32G>A | p.Arg11Gln | missense_variant | 2/8 | ENST00000318596.8 | |
SLC25A42 | NM_001321544.2 | c.32G>A | p.Arg11Gln | missense_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC25A42 | ENST00000318596.8 | c.32G>A | p.Arg11Gln | missense_variant | 2/8 | 1 | NM_178526.5 | P1 | |
SLC25A42 | ENST00000594070.5 | n.214G>A | non_coding_transcript_exon_variant | 1/5 | 2 | ||||
SLC25A42 | ENST00000597661.5 | n.95G>A | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000594 AC: 9AN: 151566Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251214Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135824
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461840Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727222
GnomAD4 genome AF: 0.0000594 AC: 9AN: 151566Hom.: 0 Cov.: 32 AF XY: 0.0000945 AC XY: 7AN XY: 74036
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.32G>A (p.R11Q) alteration is located in exon 2 (coding exon 1) of the SLC25A42 gene. This alteration results from a G to A substitution at nucleotide position 32, causing the arginine (R) at amino acid position 11 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 11 of the SLC25A42 protein (p.Arg11Gln). This variant is present in population databases (rs761258835, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SLC25A42-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at